2015
DOI: 10.4172/2329-6925.1000171
|View full text |Cite
|
Sign up to set email alerts
|

Non Valvular Atrial Fibrillation Related Ischaemic Stroke at the Teaching Hospital of Yalgado Ouédraogo, Burkina Faso

Abstract: Objectives:We aim to describe the epidemiological and prognostic characteristics of non valvular atrial fibrillation related stroke. Patients and methods:We retrospectively analyzed data of hospitalized patients from January 1 st 2010 to June 30 th 2012 in the two contiguous departments of cardiology and neurology, at the teaching hospital of Yalgado Ouédraogo, Burkina Faso. Results:We recorded 391 cases of ischaemic stroke. Cardioembolic stroke was observed in 159 patients out of who, non valvular atrial fibr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 28 publications
0
7
0
Order By: Relevance
“…AF prevalence is low in the general population of SSA at <1% and increases with age [3,15,16], 3-7% in hospital cardiology admissions or newly diagnosed cardiovascular diseases [17][18][19][20][21], 16-22% in heart failure patients [22,23], 10-14% in newly diagnosed and 18-28% in established rheumatic heart disease (RHD) patients [24][25][26], 25% in patients with tuberculous pericarditis [27], 6% de novo cases post-cardiac surgery [28], 9.5% in pregnant women with structural heart disease [29], 2-10% of de novo stroke patients [30][31][32][33], and varies between 25-65% in patients attending oral anti-coagulation clinics in SSA [34][35][36]. In SSA there is a high proportion of permanent AF (12-81.4% across studies) and persistent AF (9.6-70.6%), compared to prevalence of paroxysmal AF (8.9-50%) [20,[37][38][39][40][41] as shown in Table 1. Prominent risk factors or comorbidities associated with AF/AFL in SSA are hypertension, which is observed in 50-87% of cases, heart failure 32-64%, diabetes 4-63%, RHD 15-38%, dilated cardiomyopathy 16-38%, stroke 3-40%, and CAD 1.2-26% of AF/AFL patients ( Table 1).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…AF prevalence is low in the general population of SSA at <1% and increases with age [3,15,16], 3-7% in hospital cardiology admissions or newly diagnosed cardiovascular diseases [17][18][19][20][21], 16-22% in heart failure patients [22,23], 10-14% in newly diagnosed and 18-28% in established rheumatic heart disease (RHD) patients [24][25][26], 25% in patients with tuberculous pericarditis [27], 6% de novo cases post-cardiac surgery [28], 9.5% in pregnant women with structural heart disease [29], 2-10% of de novo stroke patients [30][31][32][33], and varies between 25-65% in patients attending oral anti-coagulation clinics in SSA [34][35][36]. In SSA there is a high proportion of permanent AF (12-81.4% across studies) and persistent AF (9.6-70.6%), compared to prevalence of paroxysmal AF (8.9-50%) [20,[37][38][39][40][41] as shown in Table 1. Prominent risk factors or comorbidities associated with AF/AFL in SSA are hypertension, which is observed in 50-87% of cases, heart failure 32-64%, diabetes 4-63%, RHD 15-38%, dilated cardiomyopathy 16-38%, stroke 3-40%, and CAD 1.2-26% of AF/AFL patients ( Table 1).…”
Section: Resultsmentioning
confidence: 99%
“…Despite the relatively lower prevalence of AF in people of African descent, the presence of AF is associated with higher rates of strokes, heart failure, and mortality compared to Caucasians, and Black patients with AF are much younger than patients of other races [123]. Atrial fibrillation was seen in 43-82% of patients with cardio-embolic strokes in SSA [40,46]. Uncontrolled hypertension, low use of anticoagulation due less access and high costs (especially non-vitamin K-dependent oral anticoagulants) and poor time in the therapeutic range among patients on vitamin K-dependent oral anticoagulants, low use of heart failure medication, and late presentation with complications are plausible reasons for this increased risk of adverse outcomes.…”
Section: Atrial Fibrillation/atrial Fluttermentioning
confidence: 99%
“…Only 5.26% of patients who should benefit from OAC received VKA. The OAC prescription rate in patients with AF is very contrasting but globally low in SSA [4, 7, 11, 22, 23, 29] compared with data from Europe with over 80% of eligible patients being anticoagulated [30]. Constraints on OAC prescription in our site comprised financial aspects, difficulties in monitoring INRs, particularly geographic access.…”
Section: Discussionmentioning
confidence: 99%
“…Hospital-based studies revealed that the prevalence of AF in SSA is ranging from 4.6 to 10.6% [47]. AF is strongly associated with an increased morbidity, such as stroke/systemic embolism or heart failure [811], and high risk of mortality [2, 11]. Healthcare systems in SSA are also characterized by limitations in human and financial resources and geographical access [12].…”
Section: Introductionmentioning
confidence: 99%
“…Besides, never screened people could not be respectful with the healthy lifestyle behaviours [28], such as the practice of physical activity, fruit and vegetables consumption, abstention to the alcohol/tobacco use, etc. It can be hypothesized that this level of unknown hypertension may contribute to the high number of surprising cardiocerebrovascular events recorded in Burkina Faso hospital setting: in 58%; 66%; 76% and 86% of patients with respectively acute coronary syndromes [29] cardioembolic disorders [30] stroke [31] and non-valvular atrial brillation [32], hypertension was reported.…”
Section: Discussionmentioning
confidence: 99%